Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$35.53

1.62 (4.78%)

13:46
01/04/18
01/04
13:46
01/04/18
13:46

Audentes price target raised to $56 from $29 at Wedbush

Wedbush analyst David Nierengarten raised his price target for Audentes Therapeutics to $56 saying the first dose cohort data from the Phase 1/2 trial for AT132 in X-Linked Myotubular Myopathy is "impressive." Treated patients experienced "significant and rapid improvements in several important functional metrics," Nierengarten tells investors in a research note. The analyst expects additional confirmatory updates throughout the year and keeps an Outperform on Audentes shares.

  • 04

    Jan

BOLD Audentes Therapeutics
$35.53

1.62 (4.78%)

12/05/17
BMOC
12/05/17
INITIATION
Target $35
BMOC
Outperform
Audentes Therapeutics initiated with an Outperform at BMO Capital
BMO Capital analyst Matthew Luchini started Audentes Therapeutics with an Outperform rating and $35 price target. The company is an "emerging" gene therapy company focused on treating rare diseases with few or no treatment options, the analyst tells investors in a research note. He believes its pipeline provides opportunities for long-term upside.
12/12/17
PIPR
12/12/17
NO CHANGE
Target $36
PIPR
Overweight
Audentes Therapeutics stock to run further on AT132 data, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond assumed coverage of Audentes Therapeutics with an Overweight rating and a price target of $36. Raymond says that despite the 56% year-to-date price gain, shares are "poised for another leg higher" on initial human data on lead program AT132 next month and second program AT342 for Crigler Najjar starting to dose patients in its Phase 1/2 VALENS study in Q1 of 2018.
12/20/17
HCWC
12/20/17
INITIATION
Target $37
HCWC
Buy
Audentes Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay started Audentes Therapeutics with a Buy rating and $37 price target. The analyst views the company's market positioning in AAV-based gene therapy as compelling and believes 2018 is "catalyst-filled."
01/04/18
PIPR
01/04/18
NO CHANGE
Target $45
PIPR
Overweight
Piper ups Audentes target to $45 on 'far' better than expected data
Piper Jaffray analyst Christopher Raymond raised his price target for Audentes Therapeutics to $45 from $36 saying the initial data for AT132 in X-Linked Myotubular Myopathy is "far" better than expected." The stock in morning trading is up 13% to $40.08. While elevated troponin levels seen in one patient is noteworthy, mitigating circumstances, combined with "truly remarkable efficacy," more than offsets this concern, Raymond tells investors in a research note. The analyst believes six month data next quarter is likely to solidify AT132's therapeutic premise. He remains a buyer of Audentes shares with an Overweight rating.

TODAY'S FREE FLY STORIES

PCG

PG&E

$17.77

-7.89 (-30.75%)

18:28
11/15/18
11/15
18:28
11/15/18
18:28
Periodicals
CPUC doesn't want PG&E to go into bankruptcy, Bloomberg says »

A California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

18:24
11/15/18
11/15
18:24
11/15/18
18:24
Periodicals
SEC investigating a company's $50M cryptocurrency sale, WSJ reports »

The SEC is investigating…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$17.77

-7.89 (-30.75%)

18:23
11/15/18
11/15
18:23
11/15/18
18:23
Hot Stocks
PG&E cut to Baa3 from Baa2 by Moody's, could be cut further »

Moody's downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$8.31

-0.14 (-1.66%)

18:10
11/15/18
11/15
18:10
11/15/18
18:10
Hot Stocks
Limbach Holding lowers FY18 EBITDA view to $8M-$10M from $18M-$20M »

Backs FY18 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NVDA

Nvidia

$202.65

5.43 (2.75%)

18:08
11/15/18
11/15
18:08
11/15/18
18:08
Hot Stocks
Nvidia CEO says the ramp of Turing GPU is 'going great' »

Says Turing represents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

BDRBF

Bombardier

$0.00

(0.00%)

18:06
11/15/18
11/15
18:06
11/15/18
18:06
Hot Stocks
Bombardier intends to fully cooperate with AMF review »

Bombardier said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

18:04
11/15/18
11/15
18:04
11/15/18
18:04
Hot Stocks
Breaking Hot Stocks news story on Nvidia »

Nvidia CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

18:01
11/15/18
11/15
18:01
11/15/18
18:01
Hot Stocks
Nvidia CEO says came into Q3 with excess inventory from crypto overhang »

Says the decline in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

TDW

Tidewater

$25.71

1.22 (4.98%)

17:52
11/15/18
11/15
17:52
11/15/18
17:52
Hot Stocks
Tidewater CFO Quinn Fanning steps down, succeeded by Gulfmark CEO Quintin Kneen »

Tidewater CFO Quinn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

17:52
11/15/18
11/15
17:52
11/15/18
17:52
Hot Stocks
Nvidia CEO expects to continue seeing demand in data center business »

Says because CPUs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

ISR

IsoRay

$0.39

-0.0051 (-1.29%)

17:51
11/15/18
11/15
17:51
11/15/18
17:51
Hot Stocks
IsoRay director Philip Vitale buys 30K shares of company stock »

IsoRay director Philip…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

17:50
11/15/18
11/15
17:50
11/15/18
17:50
Hot Stocks
Breaking Hot Stocks news story on Nvidia »

Nvidia sees FY19 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

NVDA

Nvidia

$202.65

5.43 (2.75%)

17:49
11/15/18
11/15
17:49
11/15/18
17:49
Hot Stocks
Breaking Hot Stocks news story on Nvidia »

Nvidia says its outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

ADES

Advanced Emissions

$9.71

-0.17 (-1.72%)

17:40
11/15/18
11/15
17:40
11/15/18
17:40
Hot Stocks
Breaking Hot Stocks news story on Advanced Emissions »

Advanced Emissions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMT

America's Car-Mart

$71.90

-0.495 (-0.68%)

17:38
11/15/18
11/15
17:38
11/15/18
17:38
Earnings
America's Car-Mart reports Q2 EPS $1.58 vs. 79c last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

NVDA

Nvidia

$202.65

5.43 (2.75%)

17:35
11/15/18
11/15
17:35
11/15/18
17:35
Hot Stocks
Nvidia says its competitive position is as strong as ever »

Says the company remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

HRB

H&R Block

$28.18

-0.07 (-0.25%)

17:35
11/15/18
11/15
17:35
11/15/18
17:35
Syndicate
Breaking Syndicate news story on H&R Block »

H&R Block files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEL

American Equity

$34.34

0.105 (0.31%)

17:26
11/15/18
11/15
17:26
11/15/18
17:26
Hot Stocks
American Equity raises annual dividend 8% to 28c per share »

American Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXGN

AxoGen

$32.97

0.78 (2.42%)

17:26
11/15/18
11/15
17:26
11/15/18
17:26
Hot Stocks
AxoGen directorGregory Freitag sells 20K shares of company stock »

AxoGen director Gregory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NI

NiSource

$25.30

-0.3 (-1.17%)

17:25
11/15/18
11/15
17:25
11/15/18
17:25
Hot Stocks
NiSource says 'thoroughly reviewing' NTSB safety recommendation report »

NiSource released the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVMT

Dell Technologies

$105.06

-0.69 (-0.65%)

17:25
11/15/18
11/15
17:25
11/15/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Dell Technologies »

Dodge & Cox reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GNBC

Green Bancorp

$18.71

0.53 (2.92%)

, VBTX

Veritex

$23.60

0.66 (2.88%)

17:25
11/15/18
11/15
17:25
11/15/18
17:25
Conference/Events
Veritex to host special shareholder meeting »

Special Shareholder…

GNBC

Green Bancorp

$18.71

0.53 (2.92%)

VBTX

Veritex

$23.60

0.66 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

HP

Helmerich & Payne

$60.05

1.75 (3.00%)

17:24
11/15/18
11/15
17:24
11/15/18
17:24
Hot Stocks
Breaking Hot Stocks news story on Helmerich & Payne »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

HP

Helmerich & Payne

$60.05

1.75 (3.00%)

17:23
11/15/18
11/15
17:23
11/15/18
17:23
Earnings
Helmerich & Payne reports Q4 EPS 2c, may not compare to consensus 18c »

Reports Q4 revenue $697M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

AKBA

Akebia

$7.91

0.44 (5.89%)

, KERX

Keryx

$2.93

0.17 (6.16%)

17:19
11/15/18
11/15
17:19
11/15/18
17:19
Hot Stocks
Akebia and Keryx announce chairperson for combined company »

Akebia Therapeutics…

AKBA

Akebia

$7.91

0.44 (5.89%)

KERX

Keryx

$2.93

0.17 (6.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 11

    Dec

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.